Clinical Trials
37 trialsctDNA
Institute of Oncology Ljubljana
M7824 Related Adverse Effects in Adults With Cancer
National Institutes of Health Clinical Center (CC)
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
Memorial Sloan Kettering Cancer Center
ELEPHAS-02
Elephas
ARTACUS
Replimune, Inc.
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
Iovance Biotherapeutics, Inc.
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
Pfizer
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
University of Southern California
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
H. Lee Moffitt Cancer Center and Research Institute
CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis
Istanbul Training and Research Hospital
A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma
Regeneron Pharmaceuticals
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer
Alliance for Clinical Trials in Oncology
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Artificial Intelligence Patient App for RDEB SCCs
Northwestern University
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
Memorial Sloan Kettering Cancer Center
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer
University of Southern California
BCC-HIFU2101
Bispebjerg Hospital
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
NYU Langone Health
SiroSkin
Melanoma and Skin Cancer Trials Limited
A Model for Genetic Susceptibility: Melanoma
Memorial Sloan Kettering Cancer Center
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
Regeneron Pharmaceuticals
IMAGE
Melanoma and Skin Cancer Trials Limited
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs
Maastricht University Medical Center
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Maastricht University Medical Center
DermScan
Barco NV
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
Checkpoint Therapeutics, Inc.
Patient Satisfaction in Cutaneous Surgery
Northwestern University
Impact of Sunscreen Dispensers in Parks Visited by Teenagers
Harvard School of Public Health (HSPH)